NCDActive
Cryosurgery of Prostate
NCD123
Effective: July 1, 2001
Updated: December 31, 2025
Policy Summary
Cryosurgery is covered as a primary treatment for clinically localized prostate cancer (stages T1–T3). Salvage cryosurgery is covered only for localized recurrent prostate cancer after documented failure of a trial of radiation therapy and when the patient meets specified tumor criteria (e.g., stage T2B or below and a Gleason score threshold noted by policy but not specified in this extract). Services performed before June 30, 2001 are not covered, and salvage cryosurgery following failure of non-radiation primary therapies is excluded.
Coverage Criteria Preview
Key requirements from the full policy
"Cryosurgery is covered as a primary treatment for clinically localized prostate cancer stages T1 through T3."
Sign up to see full coverage criteria, indications, and limitations.